Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donor NK Cell Infusion After Haplo-HCT
NCT00823524Phase 2Completed
- Sponsor
- Asan Medical Center
- Start
- Jan 2009
- Primary completion
- Feb 2013
- Modality
- Lymphokine-Activated Killer Cells, CAR-NK Cells
- Countries
- 1
01
Overview
A Phase 2 trial of donor natural killer cell infusion in leukemia, lymphoma, multiple myeloma (MM), myelodysplastic syndrome (MDS), myeloproliferative neoplasms (MPN), sponsored by Asan Medical Center. Started Jan 2009; status: completed.
02
Drugs
donor natural killer cell infusion
03
Conditions
leukemialymphomamultiple myeloma (MM)myelodysplastic syndrome (MDS)myeloproliferative neoplasms (MPN)
Beyond the preview
Go deeper on NCT00823524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00823524.